Archus gets $10m loan from GE:
This article was originally published in Clinica
Redmond, Washington-based Archus Orthopedics has secured a $10m venture loan from GE Healthcare Financial Services. The funds will be used to advance development of Archus' Total Facet Arthroplasty System (TFAS), which has been in US clinical trials since August 2005. The products is a spinal implant designed to treat spinal stenosis without the need to fuse the spine.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.